Cover Image
Market Research Report

Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024

Published by MarketsandMarkets Product code 265105
Published Content info 239 Pages
Delivery time: 1-2 business days
Price
Back to Top
Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024
Published: June 14, 2019 Content info: 239 Pages
Description

"The biomaterials market is projected to grow at a CAGR of 14.5% during the forecast period (2019-2024)."

The biomaterials market is projected to reach USD 207 billion by 2024 from USD 105 billion in 2019, at a CAGR of 14.5%. The growth of the biomaterials market is mainly driven by the increasing funds and grants by government bodies and universities for the development of novel biomaterials. Additionally, the increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidence of cardiovascular diseases, and rising awareness and research on regenerative medicine are the factors responsible for the growth of this market. However, limitations of biomaterials-based products and the shortage of skilled surgeons are the major challenges faced by market players.

By type, the polymeric biomaterials segment is expected to register the highest growth during the forecast period.

Based on type, the biomaterials market is segmented into metallic, polymeric, ceramic, and natural biomaterials. The polymeric biomaterials segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing use of polymers in soft-tissue applications such as plastic surgeries. However, polymers are costly, which can hinder the growth of this market.

By application, the cardiovascular applications segment dominates the biomaterials market

The cardiovascular applications segment accounted for the largest share of the biomaterials market in 2018. The large share of this segment is attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, the growing number of angiography procedures, and the increasing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators. According to the American Academy of Orthopedic Surgeons (AAOS), the number of total hip replacement surgeries performed are projected to grow to 635,000 surgeries by 2030.

"APAC is expected to witness the highest growth during the forecast period."

North America accounted for the largest share of the biomaterials market in 2018, followed by Europe. The large share of the market in North America is attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases. However, the APAC region is expected to witness the highest CAGR during the forecast period. The growth in this market is attributed to Japan's growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policy in China.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1: 55%, Tier 2: 25%, and Tier 3: 20%
  • By Designation: C-level: 43%, Director-level: 32%, and Others: 25%
  • By Region: North America: 38%, Europe: 23%, Asia Pacific: 29%, and the Rest of the World: 10%

The prominent players in the biomaterials market are: Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

Research Coverage:

The report analyzes the biomaterials market and aims at estimating the market size and future growth potential of the biomaterials market and the different segments (type, application, and region). The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the biomaterials market.
  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the biomaterials market.
  • Market Development: Comprehensive information on lucrative emerging regions.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the biomaterials market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of the leading players in the biomaterials market.
Table of Contents
Product Code: BT 1556

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. RESEARCH DESIGN
  • 2.3. SECONDARY DATA
    • 2.3.1. PRIMARY DATA
      • 2.3.1.1. Key data from primary sources
      • 2.3.1.2. Key industry insights
  • 2.4. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY:

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOMATERIALS MARKET OVERVIEW
  • 4.2. BIOMATERIALS MARKET, BY TYPE, 2018(USD BILLION)
  • 4.3. BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increased funds and grants by government bodies and universities for the development of novel biomaterials
      • 5.2.1.2. Increasing demand for implantable devices
      • 5.2.1.3. Growing demand for biomaterials in plastic surgery and wound healing applications
      • 5.2.1.4. Rising incidence of cardiovascular diseases
      • 5.2.1.5. Increasing research on regenerative medicine
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent clinical & regulatory processes
      • 5.2.2.2. Unfavorable healthcare reforms in the US
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing healthcare market in emerging economies
      • 5.2.3.2. Increasing number of free-trade agreements
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Limitations of biomaterial-based products
      • 5.2.4.2. Shortage of skilled surgeons

6. REGULATORY ASSESSMENT

  • 6.1. INTRODUCTION
  • 6.2. US
    • 6.2.1. INTRODUCTION
    • 6.2.2. FDA DEVICE CLASSIFICATION
    • 6.2.3. US: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.2.4. STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS
  • 6.3. CANADA
    • 6.3.1. INTRODUCTION
    • 6.3.2. CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.3.3. HEALTH CANADA CLASSIFICATION
  • 6.4. EUROPE
    • 6.4.1. INTRODUCTION
    • 6.4.2. EUROPEAN MEDICAL DEVICE CLASSIFICATION
    • 6.4.3. EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.4.4. EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE
  • 6.5. JAPAN
    • 6.5.1. INTRODUCTION
    • 6.5.2. PMDA DEVICE CLASSIFICATION
    • 6.5.3. JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.5.4. REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN
  • 6.6. CHINA
    • 6.6.1. INTRODUCTION
    • 6.6.2. CFDA DEVICE CLASSIFICATION
    • 6.6.3. CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.6.4. RISING HURDLES IN THE REGULATORY PROCESS IN CHINA
  • 6.7. INDIA
    • 6.7.1. INTRODUCTION
    • 6.7.2. INDIAN MEDICAL DEVICES CLASSIFICATION
  • 6.8. AUSTRALIA
    • 6.8.1. INTRODUCTION
    • 6.8.2. TGA DEVICE CLASSIFICATION
    • 6.8.3. AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT

7. BIOMATERIALS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. METALLIC BIOMATERIALS
    • 7.2.1. STAINLESS STEEL
      • 7.2.1.1. Stainless steel dominates the metallic biomaterials market
    • 7.2.2. TITANIUM & TITANIUM ALLOYS
      • 7.2.2.1. Rising number of joint replacement procedures will drive the market for titanium biomaterials
    • 7.2.3. COBALT-CHROME ALLOYS
      • 7.2.3.1. Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys
    • 7.2.4. GOLD
      • 7.2.4.1. Expanding applications of gold nanoparticles to drive the demand for gold biomaterials
    • 7.2.5. SILVER
      • 7.2.5.1. Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products
    • 7.2.6. MAGNESIUM
      • 7.2.6.1. Biodegradable characteristic of magnesium have stimulated the growth of this market segment
  • 7.3. POLYMERIC BIOMATERIALS
    • 7.3.1. POLYMETHYLMETHACRYLATE
      • 7.3.1.1. PMMA dominates the polymeric biomaterials market
    • 7.3.2. POLYETHYLENE
      • 7.3.2.1. Wear and tear resistance of polyethylene have made it popular in hip and knee joint replacements
    • 7.3.3. POLYESTER
      • 7.3.3.1. Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications
    • 7.3.4. POLYVINYLCHLORIDE
      • 7.3.4.1. Heavy chlorine content of PVC is likely to hamper the market growth
    • 7.3.5. SILICONE RUBBER
      • 7.3.5.1. Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures
    • 7.3.6. NYLON
      • 7.3.6.1. Nylon's low weight, corrosion resistance, and wide applications are expected to drive market demand
    • 7.3.7. POLYETHERETHERKETONE
      • 7.3.7.1. PEEK is gaining popularity as a viable alternative to metals
    • 7.3.8. OTHER POLYMERIC BIOMATERIALS
  • 7.4. CERAMICS
    • 7.4.1. CALCIUM PHOSPHATE
      • 7.4.1.1. Calcium phosphate drives ceramic biomaterial market segment
    • 7.4.2. ZIRCONIA
      • 7.4.2.1. Bio-inertness and low wear rate of zirconia will boost the market growth
    • 7.4.3. ALUMINUM OXIDE
      • 7.4.3.1. Increasing use of aluminum oxide in hip replacements and dental implants to drive the market
    • 7.4.4. CALCIUM SULFATE
      • 7.4.4.1. Fast resorption rate of calcium sulfate is likely to hamper its use
    • 7.4.5. CARBON
      • 7.4.5.1. Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth
    • 7.4.6. GLASS
      • 7.4.6.1. Rising number of orthopedics and dental procedures likely to drive the demand for glass biomaterials
  • 7.5. NATURAL BIOMATERIALS
    • 7.5.1. HYALURONIC ACID
      • 7.5.1.1. Rising prevalence of osteoarthritis to drive hyaluronic acid market
    • 7.5.2. COLLAGEN
      • 7.5.2.1. Rising prevalence of target applications to drive growth in collagen market
    • 7.5.3. GELATIN
      • 7.5.3.1. Low cost of gelatin to drive its market growth
    • 7.5.4. FIBRIN
      • 7.5.4.1. Fibrin biomaterials were among the first used to prevent bleeding
    • 7.5.5. CELLULOSE
      • 7.5.5.1. Cellulose find applications in wound healing, skin regeneration, and ophthalmology
    • 7.5.6. CHITIN
      • 7.5.6.1. Chitin accelerates skin regeneration and possesses high biocompatibility
    • 7.5.7. ALGINATES
      • 7.5.7.1. Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery
    • 7.5.8. SILK
      • 7.5.8.1. The flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications

8. BIOMATERIALS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CARDIOVASCULAR
    • 8.2.1. CATHETERS
    • 8.2.2. STENTS
    • 8.2.3. IMPLANTABLE CARDIAC DEFIBRILLATORS
    • 8.2.4. PACEMAKERS
    • 8.2.5. SENSORS
    • 8.2.6. HEART VALVES
    • 8.2.7. VASCULAR GRAFTS
    • 8.2.8. GUIDEWIRES
    • 8.2.9. OTHERS
  • 8.3. ORTHOPEDIC
    • 8.3.1. JOINT REPLACEMENT
      • 8.3.1.1. Knee Replacement
      • 8.3.1.2. Hip Replacement
      • 8.3.1.3. Shoulder Replacement
      • 8.3.1.4. Others
    • 8.3.2. VISCOSUPPLEMENTATION
    • 8.3.3. BIORESORBABLE TISSUE FIXATION
      • 8.3.3.1. Suture anchors
      • 8.3.3.2. Interference screws
      • 8.3.3.3. Meniscal repair tacks
      • 8.3.3.4. Meshes
    • 8.3.4. SPINE
      • 8.3.4.1. Spinal Fusion Surgeries
      • 8.3.4.2. Minimally Invasive Fusion Surgeries
      • 8.3.4.3. Motion Preservation & Dynamic Stabilization Surgeries
        • 8.3.4.3.1. Pedicle-based rod systems
        • 8.3.4.3.2. Interspinous spacers
        • 8.3.4.3.3. Artificial Discs
    • 8.3.5. FRACTURE FIXATION DEVICES
      • 8.3.5.1. Bone plates
      • 8.3.5.2. Screws
      • 8.3.5.3. Pins
      • 8.3.5.4. Rods
      • 8.3.5.5. Wires
    • 8.3.6. SYNTHETICS BONE GRAFTS
  • 8.4. OPHTHALMOLOGY
    • 8.4.1. INCREASING PREVALENCE OF EYE DISEASES TO DRIVE MARKET GROWTH
    • 8.4.2. CONTACT LENSES
    • 8.4.3. INTRAOCULAR LENSES
    • 8.4.4. FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
    • 8.4.5. SYNTHETIC CORNEAS
    • 8.4.6. OTHERS
  • 8.5. DENTAL
    • 8.5.1. SYNTHETIC DENTAL BIOMATERIALS INCLUDE METALS, CERAMICS, POLYMERS, AND COMPOSITE STRUCTURES
    • 8.5.2. DENTAL IMPLANTS
    • 8.5.3. DENTAL BONE GRAFTS & SUBSTITUTES
    • 8.5.4. DENTAL MEMBRANES
    • 8.5.5. TISSUE REGENERATION
  • 8.6. PLASTIC SURGERY
    • 8.6.1. GROWING NUMBER OF COSMETIC SURGERIES PERFORMED TO DRIVE THE MARKET FOR BIOMATERIALS
    • 8.6.2. SOFT-TISSUE FILLERS
    • 8.6.3. CRANIOFACIAL SURGERY
  • 8.7. WOUND HEALING
    • 8.7.1. BIOMATERIALS ARE EXTENSIVELY USED IN VARIOUS WOUND HEALING PRODUCTS
    • 8.7.2. WOUND CLOSURE DEVICES
      • 8.7.2.1. Sutures
      • 8.7.2.2. Staples
    • 8.7.3. SURGICAL HEMOSTATS
    • 8.7.4. INTERNAL TISSUE SEALANTS
    • 8.7.5. ADHESION BARRIERS
    • 8.7.6. HERNIA MESHES
  • 8.8. TISSUE ENGINEERING
    • 8.8.1. INCREASING DEMAND FOR ENHANCED MECHANICAL PERFORMANCE OF TISSUE-ENGINEERED IMPLANTS TO SUPPORT THE GROWTH OF THIS APPLICATION SEGMENT
    • 8.8.2. SCAFFOLDS FOR REGENERATIVE MEDICINE
    • 8.8.3. NANOMATERIALS FOR BIOSENSING
    • 8.8.4. TAILORING OF INORGANIC NANOPARTICLES
  • 8.9. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
    • 8.9.1. THE MAJOR APPLICATION AREAS OF BIOMATERIALS IN CNS DISORDERS INCLUDE SHUNTING, CORTICAL NEURAL PROSTHESIS, AND NEURAL STEM CELL ENCAPSULATION
    • 8.9.2. SHUNTING SYSTEMS
    • 8.9.3. CORTICAL NEURAL PROSTHETICS
    • 8.9.4. HYDROGEL SCAFFOLDS FOR CNS REPAIR
    • 8.9.5. NEURAL STEM CELL ENCAPSULATION
  • 8.10. OTHER APPLICATIONS
    • 8.10.1. DRUG DELIVERY SYSTEMS
    • 8.10.2. GASTROINTESTINAL APPLICATIONS
    • 8.10.3. BARIATRIC SURGERY
    • 8.10.4. URINARY APPLICATIONS

9. BIOMATERIALS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. US dominates the North American biomaterials market
    • 9.2.2. CANADA
      • 9.2.2.1. Increasing incidence of cardiovascular diseases to drive market growth in Canada
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Large medical devices market to support the adoption of biomaterials in Germany
    • 9.3.2. UK
      • 9.3.2.1. Availability of funds and rising cardiovascular procedures to drive the biomaterials market in the UK
    • 9.3.3. FRANCE
      • 9.3.3.1. Rising aging population and associated diseases to drive the market in France
    • 9.3.4. SPAIN
      • 9.3.4.1. Increasing research activities on biomaterials to drive the growth in Spain
    • 9.3.5. REST OF EUROPE (ROE)
  • 9.4. ASIA PACIFIC
    • 9.4.1. JAPAN
      • 9.4.1.1. Growing medical devices industry to drive market growth
    • 9.4.2. CHINA
      • 9.4.2.1. Lucrative medical devices industry in China
    • 9.4.3. INDIA
      • 9.4.3.1. Large population base and growing medical tourism in India to drive the growth of biomaterials
    • 9.4.4. REST OF ASIA PACIFIC (ROAPAC)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SCENARIO
    • 10.2.1. PRODUCT LAUNCHES
    • 10.2.2. MERGERS AND ACQUISITIONS
    • 10.2.3. EXPANSIONS
  • 10.3. COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2018)
    • 10.3.1. VISIONARY LEADERS
    • 10.3.2. INNOVATORS
    • 10.3.3. DYNAMIC DIFFERENTIATORS
    • 10.3.4. EMERGING COMPANIES
  • 10.4. COMPETITIVE LEADERSHIP MAPPING (START-UP) (2018)
    • 10.4.1. PROGRESSIVE COMPANIES
    • 10.4.2. STARTING BLOCKS
    • 10.4.3. DYNAMIC COMPANIES
    • 10.4.4. RESPONSIVE COMPANIES

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. ROYAL DSM
  • 11.2. BASF SE
  • 11.3. CORBION
  • 11.4. COVESTRO AG
  • 11.5. CARPENTER TECHNOLOGY CORPORATION
  • 11.6. EVONIK INDUSTRIES
  • 11.7. BERKELEY ADVANCED BIOMATERIALS, INC.
  • 11.8. CAM BIOCERAMICS B.V.
  • 11.9. CELANESE CORPORATION
  • 11.10. COORSTEK INC.
  • 11.11. CERAMTEC GMBH
  • 11.12. GELITA AG

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
  • TABLE 2: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 3: METALLIC BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 4: METALLIC BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 5: STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: GOLD BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: SILVER BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: APPLICATIONS OF SYNTHETIC POLYMERS
  • TABLE 12: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 13: POLYMERIC BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 14: POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: POLYESTER BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NYLON BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 23: CERAMIC BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 24: CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: CARBON BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: GLASS BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: APPLICATIONS OF NATURAL BIOMATERIALS
  • TABLE 31: NATURAL BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 32: NATURAL BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 33: HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: COLLAGEN BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: GELATIN BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: FIBRIN BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: CELLULOSE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: CHITIN BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: ALGINATE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: SILK BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 42: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2017-2024 (USD BILLION)
  • TABLE 43: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 44: BIOMATERIALS MARKET FOR CATHETERS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 45: BIOMATERIALS MARKET FOR STENTS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 46: BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 47: BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION, 2017-2024(USD BILLION)
  • TABLE 48: BIOMATERIALS MARKET FOR SENSORS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 49: BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
  • TABLE 50: BIOMATERIALS MARKET FOR HEART VALVES, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 51: BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 52: BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2017-2024(USD BILLION)
  • TABLE 53: BIOMATERIALS MARKET FOR OTHER CARDIOVASCULAR APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 54: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 55: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 56: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 57: JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 58: KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 59: HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 60: SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 61: OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 62: VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63: BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT, 2017-2024 (USD BILLION)
  • TABLE 64: BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 65: BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION, 2017-2024(USD MILLION)
  • TABLE 66: BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 67: BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2017-2024(USD MILLION)
  • TABLE 68: BIOMATERIALS MARKET FOR MESHES, BY REGION, 2017-2024(USD MILLION)
  • TABLE 69: BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 70: BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 71: BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 72: BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 73: BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 74: BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 75: BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 76: BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 77: BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 78: BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 79: BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 80: BIOMATERIALS MARKET FOR BONE PLATES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 81: BIOMATERIALS MARKET FOR SCREWS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 82: BIOMATERIALS MARKET FOR PINS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 83: BIOMATERIALS MARKET FOR RODS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 84: BIOMATERIALS MARKET FOR WIRES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 85: BIOMATERIALS MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 86: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 87: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 88: BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 89: BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 90: BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 91: BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 92: BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 93: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2017-2024 (USD BILLION)
  • TABLE 94: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 95: PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN THE US (2016)
  • TABLE 96: BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 97: BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 98: BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 99: BIOMATERIALS MARKET FOR TISSUE REGENERATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 100: BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 101: BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 102: BIOMATERIALS MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 103: BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 104: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2017-2024 (USD BILLION)
  • TABLE 105: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 106: BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 107: BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 108: BIOMATERIALS MARKET FOR SUTURES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 109: BIOMATERIALS MARKET FOR STAPLES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 110: BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 111: BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 112: BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 113: BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 114: TISSUE ENGINEERING BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 115: TISSUE ENGINEERING BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 116: TISSUE ENGINEERING BIOMATERIALS MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 117: TISSUE ENGINEERING BIOMATERIALS MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 118: TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 119: BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 120: BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 121: BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 122: BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 123: BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 124: BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 125: OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 127: BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 128: BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 129: BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 130: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 131: BIOMATERIALS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 132: NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 133: NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 134: NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 135: US: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 136: US: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 137: CANADA: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 138: CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 139: EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 140: EUROPE: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 141: EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 142: GERMANY: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 143: GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 144: UK: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 145: UK: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 146: FRANCE: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 147: FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 148: SPAIN: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 149: SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 150: ROE: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 151: ROE: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 152: APAC: BIOMATERIALS MARKET, BY COUNTRY/REGION, 2017-2024 (USD BILLION)
  • TABLE 153: APAC: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 154: APAC: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 155: JAPAN: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 156: JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 157: CHINA: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 158: CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 159: INDIA: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 160: INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 161: ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 162: ROAPAC: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 163: ROW: BIOMATERIALS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 164: ROW: BIOMATERIALS MARKET, BY APPLICATION, 2017-2024 (USD BILLION)
  • TABLE 165: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, BY COMPANIES (2015-2019)
  • TABLE 166: PRODUCT LAUNCHES BY COMPANIES (2015-2019)
  • TABLE 167: MERGER AND ACQUISITIONS BY COMPANIES (2015-2018)
  • TABLE 168: EXPANSIONS BY COMPANIES (2015-2019)

LIST OF FIGURES

  • FIGURE 1: GLOBAL BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH METHODOLOGY: BIOMATERIALS MARKET
  • FIGURE 3: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION)
  • FIGURE 8: METALLIC BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION)
  • FIGURE 9: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION)
  • FIGURE 10: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION)
  • FIGURE 11: NATURAL BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION)
  • FIGURE 12: PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE BIOMATERIALS MARKET
  • FIGURE 14: INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET
  • FIGURE 15: METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: US: REGULATORY APPROVAL PROCESS
  • FIGURE 19: REGULATORY APPROVAL TIMELINE IN THE US
  • FIGURE 20: CANADA: REGULATORY APPROVAL PROCESS
  • FIGURE 21: REGULATORY APPROVAL TIMELINE IN CANADA
  • FIGURE 22: EUROPE: REGULATORY APPROVAL PROCESS
  • FIGURE 23: REGULATORY APPROVAL TIMELINE IN EUROPE
  • FIGURE 24: JAPAN: REGULATORY APPROVAL PROCESS
  • FIGURE 25: REGULATORY APPROVAL TIMELINE IN JAPAN
  • FIGURE 26: CHINA: REGULATORY APPROVAL PROCESS
  • FIGURE 27: REGULATORY APPROVAL TIMELINE IN CHINA
  • FIGURE 28: INDIA: REGULATORY APPROVAL PROCESS
  • FIGURE 29: AUSTRALIA: REGULATORY APPROVAL PROCESS
  • FIGURE 30: REGULATORY APPROVAL TIMELINE IN AUSTRALIA
  • FIGURE 31: POLYMERIC BIOMATERIALS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 32: TITANIUM AND TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 33: PMMA SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 34: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2017 VS 2024
  • FIGURE 35: HYALURONIC ACID SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 36: PLASTIC SURGERY SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 37: STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 38: JOINT REPLACEMENT TO DOMINATE THE ORTHOPEDIC BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 39: CONTACT LENSES SEGMENT TO DOMINATE THE BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS DURING THE FORECAST PERIOD
  • FIGURE 40: DENTAL IMPLANTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE DENTAL BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 41: SOFT-TISSUE FILLERS SEGMENT WILL CONTINUE TO DOMINATE THE BIOMATERIALS MARKET FOR PLASTIC SURGERY IN 2024
  • FIGURE 42: INTERNAL TISSUE SEALANTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 43: SCAFFOLDS FOR REGENERATIVE MEDICINE SEGMENT TO DOMINATE THE TISSUE ENGINEERING BIOMATERIALS MARKET IN 2018
  • FIGURE 44: CORTICAL NEURAL PROSTHETICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 45: BIOMATERIALS MARKET, BY REGION, 2019 VS. 2024 (USD BILLION)
  • FIGURE 46: NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 47: EUROPE: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 48: ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 49: ROW: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 50: KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS
  • FIGURE 51: COMPETITIVE LEADERSHIP MAPPING: BIOMATERIALS MARKET
  • FIGURE 52: COMPETITIVE LEADERSHIP MAPPING: BIOMATERIALS MARKET
  • FIGURE 53: ROYAL DSM: COMPANY SNAPSHOT
  • FIGURE 54: BASF: COMPANY SNAPSHOT
  • FIGURE 55: CORBION: COMPANY SNAPSHOT
  • FIGURE 56: COVESTRO: COMPANY SNAPSHOT
  • FIGURE 57: CARPENTER TECHNOLOGY: COMPANY SNAPSHOT
  • FIGURE 58: EVONIK INDUSTRIES: COMPANY SNAPSHOT
  • FIGURE 59: CELANESE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 60: CERAMTEC: COMPANY SNAPSHOT
Back to Top